Folgen
andrea casadei gardini
andrea casadei gardini
San Raffaele university
Bestätigte E-Mail-Adresse bei hsr.it
Titel
Zitiert von
Zitiert von
Jahr
Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial
M Maltoni, E Scarpi, M Dall'Agata, V Zagonel, R Bertè, D Ferrari, ...
European Journal of Cancer 65, 61-68, 2016
1692016
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
G Marisi, A Cucchetti, P Ulivi, M Canale, G Cabibbo, L Solaini, FG Foschi, ...
World journal of gastroenterology 24 (36), 4152, 2018
1662018
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis
F Fornari, D Pollutri, C Patrizi, T La Bella, S Marinelli, A Casadei Gardini, ...
Clinical cancer research 23 (14), 3953-3965, 2017
1612017
Systematic versus on-demand early palliative care: a randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life
M Maltoni, E Scarpi, M Dall’Agata, S Schiavon, C Biasini, C Codecà, ...
European Journal of Cancer 69, 110-118, 2016
1552016
Systematic versus on-demand early palliative care: a randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life
M Maltoni, E Scarpi, M Dall’Agata, S Schiavon, C Biasini, C Codecà, ...
European Journal of Cancer 69, 110-118, 2016
1552016
Aberrant metabolism in hepatocellular carcinoma provides diagnostic and therapeutic opportunities
S De Matteis, A Ragusa, G Marisi, S De Domenico, A Casadei Gardini, ...
Oxidative medicine and cellular longevity 2018, 2018
1322018
BRAF-mutated colorectal cancer: clinical and molecular insights
F Caputo, C Santini, C Bardasi, K Cerma, A Casadei-Gardini, ...
International journal of molecular sciences 20 (21), 5369, 2019
1212019
Patients with advanced hepatocellular carcinoma need a personalized management: a lesson from clinical practice
EG Giannini, L Bucci, F Garuti, M Brunacci, B Lenzi, M Valente, E Caturelli, ...
Hepatology 67 (5), 1784-1796, 2018
1062018
Immunotherapy for colorectal cancer: where are we heading?
D Basile, SK Garattini, M Bonotto, E Ongaro, M Casagrande, M Cattaneo, ...
Expert opinion on biological therapy 17 (6), 709-721, 2017
1052017
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib
AC Gardini, E Scarpi, L Faloppi, M Scartozzi, N Silvestris, D Santini, ...
Oncotarget 7 (41), 67142, 2016
1032016
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale
AC Gardini, L Faloppi, S De Matteis, FG Foschi, N Silvestris, F Tovoli, ...
European Journal of Cancer 86, 106-114, 2017
942017
Shifts of faecal microbiota during sporadic colorectal carcinogenesis
G Mori, S Rampelli, BS Orena, C Rengucci, G De Maio, G Barbieri, ...
Scientific reports 8 (1), 1-11, 2018
862018
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib
A Casadei Gardini, G Marisi, E Scarpi, M Scartozzi, L Faloppi, N Silvestris, ...
Expert opinion on pharmacotherapy 16 (18), 2719-2725, 2015
742015
Predictive and prognostic factors in HCC patients treated with sorafenib
O Brunetti, A Gnoni, A Licchetta, V Longo, A Calabrese, A Argentiero, ...
Medicina 55 (10), 707, 2019
722019
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients
F Tovoli, L Ielasi, A Casadei-Gardini, A Granito, FG Foschi, G Rovesti, ...
Journal of hepatology 71 (6), 1175-1183, 2019
702019
KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)
A Casadei Gardini, L Capelli, P Ulivi, M Giannini, E Freier, S Tamberi, ...
PLoS One 9 (3), e92071, 2014
652014
Immunotherapeutic approaches for hepatocellular carcinoma
V Longo, A Gnoni, AC Gardini, S Pisconti, A Licchetta, M Scartozzi, ...
Oncotarget 8 (20), 33897, 2017
642017
Lactate dehydrogenase in hepatocellular carcinoma: something old, something new
L Faloppi, M Bianconi, R Memeo, A Casadei Gardini, R Giampieri, ...
BioMed research international 2016, 2016
642016
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis
M Rimini, L Rimassa, K Ueshima, V Burgio, S Shigeo, T Tada, G Suda, ...
ESMO open 7 (6), 100591, 2022
632022
Conversion surgery for gastric cancer: a cohort study from a western center
P Morgagni, L Solaini, M Framarini, G Vittimberga, A Gardini, D Tringali, ...
International journal of surgery 53, 360-365, 2018
632018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20